WASHINGTON (AP) More than 260 reproductive health researchers submitted a letter to the U.S. Food and Drug Administration on Wednesday affirming the safety record of the abortion medication mifepristone.
In the letter, the researchers urge the FDA not to impose new restrictions on the drug and to make decisions based on “gold-standard science.”
Dr. Marty Makary, who leads the FDA, hasn’t committed to specific action on the pill, but many Americans wonder if there will be new restrictions under the Trump administration.
Medical professionals call it “among the safest medications” ever approved by the FDA. But a Christian conservative group that sued the FDA over the drug says it has caused “tens of thousands” of “emergency complications.”
Mifepristone is typically used with misoprostol in medication abortions, which make up close to two-thirds of abortions in the U.S.